Back
NovaBay Pharmaceuticals Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
23
NBY
NovaBay Pharmaceuticals
Last Price:
0.58
Seasonality Move:
-8.54%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.57 | Buy |
| 20-day SMA: | 0.62 | Sell |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 0.58 | Sell |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 4.92 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.63 | Sell |
| Chaikin Money Flow: | 40319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.57 - 0.71) | Sell |
| Bollinger Bands (100): | (0.4 - 0.86) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.57 while NBY 8-day simple moving average is 0.57, which is a Buy signal.
- The stock price of NBY is 0.57 while NovaBay Pharmaceuticals 20-day SMA is 0.62, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.65 while NBY share price is 0.57, making it a Sell technically.
- NBY stock price is 0.57 and NovaBay Pharmaceuticals 200-day simple moving average is 2.00, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
23
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.81M
Price in USD:
0.57
Share Volume:
60.58K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
10.15
52-Week Low:
0.36
Sell
23
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.57 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.57 while NBY 8-day exponential moving average is 0.58, which is a Sell signal.
- The stock price of NBY is 0.57 while NovaBay Pharmaceuticals 20-day EMA is 0.61, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.67 while NBY share price is 0.57, making it a Sell technically.
- NBY stock price is 0.57 and NovaBay Pharmaceuticals 200-day simple moving average is 4.92, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting NovaBay Pharmaceuticals is a Sell
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 41.63, which suggest NovaBay Pharmaceuticals is oversold
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.57 - 0.71), which suggest NovaBay Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.4 - 0.86), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.